DK0650733T3 - Levende svækket in ovo-vaccine - Google Patents
Levende svækket in ovo-vaccineInfo
- Publication number
- DK0650733T3 DK0650733T3 DK94117270T DK94117270T DK0650733T3 DK 0650733 T3 DK0650733 T3 DK 0650733T3 DK 94117270 T DK94117270 T DK 94117270T DK 94117270 T DK94117270 T DK 94117270T DK 0650733 T3 DK0650733 T3 DK 0650733T3
- Authority
- DK
- Denmark
- Prior art keywords
- live
- microorganism
- ovo
- modified
- modified microorganism
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 title 1
- 244000005700 microbiome Species 0.000 abstract 5
- 241000271566 Aves Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000012447 hatching Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14720793A | 1993-11-03 | 1993-11-03 | |
| CN94117813A CN1106299A (zh) | 1993-11-03 | 1994-11-04 | 卵内活疫苗 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0650733T3 true DK0650733T3 (da) | 2002-03-11 |
Family
ID=36940636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94117270T DK0650733T3 (da) | 1993-11-03 | 1994-11-02 | Levende svækket in ovo-vaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6231871B1 (da) |
| EP (1) | EP0650733B1 (da) |
| JP (1) | JPH07206705A (da) |
| CN (1) | CN1106299A (da) |
| AT (1) | ATE211922T1 (da) |
| AU (1) | AU7763294A (da) |
| CA (1) | CA2134835C (da) |
| DE (1) | DE69429646T2 (da) |
| DK (1) | DK0650733T3 (da) |
| ES (1) | ES2169061T3 (da) |
| NZ (1) | NZ264845A (da) |
| PT (1) | PT650733E (da) |
| ZA (1) | ZA948643B (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282436B6 (sk) * | 1995-06-07 | 2002-02-05 | Pfizer Inc. | Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky |
| US6500438B2 (en) * | 1995-06-07 | 2002-12-31 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
| BR9612090A (pt) * | 1995-12-19 | 1999-12-28 | Univ Iowa State Res Found Inc | Vacina para aves domésticas heterófilo-adaptada |
| US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
| US6410222B1 (en) | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
| US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
| EP1309713A4 (en) * | 2000-01-20 | 2008-08-06 | Martek Biosciences Corp | METHOD OF RABBING RABBITS |
| ES2316492T3 (es) * | 2000-11-16 | 2009-04-16 | Intervet International Bv | Vacuna contra la salmonella. |
| CA2452841C (en) | 2001-08-30 | 2012-10-02 | Embrex, Inc. | Method of sporulating eimeria oocytes |
| US7357935B2 (en) | 2003-05-14 | 2008-04-15 | Wyeth | Avian E. coli vaccine for protection against colibacillosis |
| US7297338B2 (en) * | 2003-05-14 | 2007-11-20 | Wyeth | Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
| US7674467B2 (en) * | 2003-09-03 | 2010-03-09 | Intralytix, Inc. | Salmonella bacteriophage and uses thereof |
| CA2547775C (en) | 2003-12-03 | 2012-01-03 | Pfizer Products Inc. | In ovo vaccination of campylobacter in avian species |
| CN1276076C (zh) * | 2004-12-14 | 2006-09-20 | 华东理工大学 | 一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用 |
| US20060196428A1 (en) * | 2005-03-03 | 2006-09-07 | Correa Rafael S | Method for improving chick hatchability |
| WO2007126816A2 (en) * | 2006-03-30 | 2007-11-08 | Embrex, Inc. | Methods and compositions for vaccination of poultry |
| UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
| US7935355B2 (en) * | 2007-04-19 | 2011-05-03 | Nutritional Health Institute Laboratories, Llc | Composition and method for controlling intestinal pathogenic organisms |
| US20080260777A1 (en) * | 2007-04-19 | 2008-10-23 | Sotomayor Konky | Composition and method for controlling intestinal pathogenic organisms |
| AU2008261604B2 (en) * | 2007-06-13 | 2012-05-24 | Australian Poultry Crc Pty Ltd | Modulating production traits in avians |
| AR072976A1 (es) * | 2008-08-08 | 2010-10-06 | Wyeth Corp | Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo |
| US9687540B2 (en) | 2012-10-26 | 2017-06-27 | Intervet Inc. | Cross-protecting Salmonella vaccines |
| WO2022026687A1 (en) * | 2020-07-31 | 2022-02-03 | University Of Florida Research Foundation Incorporated | Self-destructing salmonella as innate immunity activator to improve food safety |
| JP2025508028A (ja) | 2022-03-08 | 2025-03-21 | イプラ、サイエンティフィック、エセ、エレ、ウ | コクシジウム症に対する卵内ワクチン組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2851006A (en) | 1955-11-03 | 1958-09-09 | Swift & Co | Hatching of eggs |
| US3120834A (en) | 1961-11-01 | 1964-02-11 | Vineland Poultry Lab | Method of introducing adjusvants into avian egg interiors |
| US3256856A (en) | 1964-08-19 | 1966-06-21 | Francis C Moore | Method of introducing small controlled amounts of treatment materials into avian eggs |
| US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US5210035A (en) * | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
| US4458630A (en) * | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
| EP0198828A4 (en) * | 1983-12-13 | 1986-11-04 | Commw Scient Ind Res Org | Infectious bursal disease virus vaccine. |
| IL85980A (en) * | 1987-04-16 | 1992-03-29 | Embrex Inc | Disease control in avian species by embryonal vaccination with a nonreplicating immunogen |
| US5206015A (en) | 1989-06-05 | 1993-04-27 | The United States Of America As Represented By The Secretary Of Agriculture | Introduction of bacteria in ovo |
| AU6714290A (en) * | 1989-10-02 | 1991-04-28 | Embrex Inc. | Method of treating infectious bursal disease virus |
| FR2757061B1 (fr) * | 1996-12-16 | 1999-03-26 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
| US6048535A (en) * | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
-
1994
- 1994-10-31 JP JP6290671A patent/JPH07206705A/ja active Pending
- 1994-11-01 CA CA002134835A patent/CA2134835C/en not_active Expired - Lifetime
- 1994-11-02 NZ NZ264845A patent/NZ264845A/en not_active IP Right Cessation
- 1994-11-02 PT PT94117270T patent/PT650733E/pt unknown
- 1994-11-02 DK DK94117270T patent/DK0650733T3/da active
- 1994-11-02 ES ES94117270T patent/ES2169061T3/es not_active Expired - Lifetime
- 1994-11-02 ZA ZA948643A patent/ZA948643B/xx unknown
- 1994-11-02 DE DE69429646T patent/DE69429646T2/de not_active Expired - Lifetime
- 1994-11-02 AT AT94117270T patent/ATE211922T1/de active
- 1994-11-02 AU AU77632/94A patent/AU7763294A/en not_active Abandoned
- 1994-11-02 EP EP94117270A patent/EP0650733B1/en not_active Expired - Lifetime
- 1994-11-04 CN CN94117813A patent/CN1106299A/zh active Pending
-
1996
- 1996-05-06 US US08/643,718 patent/US6231871B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT650733E (pt) | 2002-06-28 |
| ZA948643B (en) | 1995-07-07 |
| NZ264845A (en) | 1997-09-22 |
| AU7763294A (en) | 1995-05-18 |
| EP0650733A1 (en) | 1995-05-03 |
| ATE211922T1 (de) | 2002-02-15 |
| CN1106299A (zh) | 1995-08-09 |
| ES2169061T3 (es) | 2002-07-01 |
| DE69429646D1 (de) | 2002-02-21 |
| US6231871B1 (en) | 2001-05-15 |
| JPH07206705A (ja) | 1995-08-08 |
| CA2134835A1 (en) | 1995-05-04 |
| DE69429646T2 (de) | 2002-11-14 |
| EP0650733B1 (en) | 2002-01-16 |
| CA2134835C (en) | 2008-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2169061T3 (es) | Vacuna vivas in ovo. | |
| WO2000004919A3 (en) | Live attenuated salmonella vaccines to control avian pathogens | |
| SE9003198L (sv) | Fiskvaccin omfattande en virulent, invasiv bakterie | |
| CY1107188T1 (el) | Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης | |
| Heddleston et al. | Fowl cholera: immune response in turkeys | |
| HUT65367A (en) | Method for the preparation of chicken anaemia agent vaccine | |
| ES2098788T3 (es) | Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria. | |
| DK0626008T3 (da) | Vaccine, der som en adjuvans indeholder acemannan | |
| GB2331521A (en) | Vaccine preparations | |
| HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
| Richey et al. | The effect of congenital passive immunity levels on the response of chicks to Newcastle disease vaccination | |
| Gross | Escherichia coli as a complicating factor of Newcastle disease vaccination | |
| Levy et al. | Immunization of chickens with an inactivated oil-adjuvant Newcastle disease virus vaccine | |
| ATE16348T1 (de) | Ozon-inaktivierte keime als vakzine. | |
| ZA200101583B (en) | Chicken anaemia viruses of low pathogenicity. | |
| DK569985A (da) | Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus | |
| Khan et al. | In process quality control factors affecting efficacy of Avian Influenza (H5N1) vaccine | |
| DE69208854D1 (de) | Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt | |
| Sivanandan et al. | Protective efficacy of a adjuvanted Newcastle disease virus vaccine A et al. | |
| ES471766A1 (es) | Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza | |
| Saif-Edin | IMMUNIZATION OF DUCKS AGAINST PASTEURELLA MULTOCIDA INFECTION BY AVIRULENT CU STRAIN 1-EFFICACY AND SAFETY OF THE VACCINE | |
| Webster | Commercial egg tip: Competitive exclusion and vaccination for reduction of salmonella enteritidis contamination of eggs | |
| HUT37353A (en) | Process for producing vaccine for treating infective laryngitis and trachitis of fowls | |
| Gay et al. | Progeny protection against inclusion body hepatitis through maternal immunity | |
| TH62279A (th) | วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส |